Aedifica ($AED.BR) is a lesser identified Belgian healthcare REIT. It operates throughout Europe and boasts enticing fundamentals reminiscent of an 100% occupancy, ~19 yr WAULT and even a excessive EPRA yield at 8%. But the inventory has been underneath strain since 2021, is that this deserved given the modifications in rates of interest or does Aedifica at the moment current buyers with a pretty funding case?
Enterprise Profile
Aedifica is a Belgian regulated actual property firm (REIT) specializing within the funding and growth of healthcare actual property throughout Europe. The corporate focuses on senior housing and care services, addressing the growing demand pushed by demographic shifts.
Aedifica’s has long-term lease agreements, sometimes with established operators from a mixture of for revenue and non income. The corporate’s portfolio spans Belgium, Germany, the Netherlands, the UK, Finland, Eire and Spain.
Funding case
The funding case is sort of easy for Aedifica, long run tailwinds from an more and more ageing inhabitants throughout Europe supported by a pretty valuation. Let’s break these down:
Demand drivers
The inhabitants in Europe is ageing, the share of these aged 80 years or above within the EU’s inhabitants is projected to have a 2.5 fold improve between 2024 and 2100, from 6.1% to fifteen.3%. It will require extra satisfactory housing and care services which already should not maintaining in lots of international locations.
Determine 1: twenty first century growth of inhabitants throughout the EU
Tenants
Those immediately benefiting from the aforementioned tendencies are the operators of those care services. Consider corporations reminiscent of Korian or non income reminiscent of Leger des Heils. They’ve had some after results from covid by means of decrease occupancy, elevated labor prices and better charges. The scenario for Aedifica´s tennants is enhancing although.

Determine 2: Tenant occupancy charges
Yields
As a REIT Aedifica in fact may be very depending on rate of interest modifications, these have an effect on their rate of interest prices and property values and probably the unfold between borrowing and rental yields. In decrease yield environments Aedifica traded at greater than €120 a share nonetheless as charges elevated the share acquired minimize in half.
Valuation
As I do not need a crystal ball which incorporates the ECBs charges on the finish of the last decade I valued Aedifica from a situation based mostly method.
Excessive RFR
Base case (present yield)
Low RFR
LTM EPRA yield
10%
7.98%
4%
Present share value
61.90
61.90
61.90
Ending share value
57.43
71.98
143.58
Collected EPRA per share
24.39
27.10
29.81
Whole
81.83
99.08
173.40
ARR
6.44%
12.01%
36.03%
Desk 1: Quite simple valuation based mostly on 5 years of forecasting, RFR = danger free price
The 4% EPRA yield noticed through the publish covid low yield atmosphere may very well be repeated once more which for my part shouldn’t be unlikely given the present political scenario in Europe. Even when charges keep the identical to now a really enticing double digit annual return might be noticed. That is based mostly in Aedifica adjusting to greater charges, 2025 and 2026 will probably be transitional years on this case. If charges had been to start out growing once more (I’ve doubts the ECB would improve it far more from current highs) a optimistic return stays because of the excessive EPRA technology potential of Aedifica.
Dangers
Charges
Aedifica ($AED.BR) is rated BBB however considerably greater charges might put strain on them from three sides: decrease asset values, elevated monetary bills and tenant credit score deterioration. Refinancing is unfold out comparatively evenly as debt will get rolled over, brief time period most debt is fastened in any case so most rate of interest modifications would go into refinanced debt price and hamper development.


Determine 4: Debt sorts
Demand modifications
If Europeans handle to dwell longer at dwelling at a price which compensates for absolutely the quantity development in aged this might have an affect on the occupancy ranges of Aedifica´s tenants.
Massive tenants
Aedifica does have some tenant focus with Clariane which is publicly traded and has not carried out nicely, nonetheless their portfolio expansions are additionally diversifying away from giant single tenants and enhance geographical diversification as nicely decreasing regulatory danger from sure international locations.

Conclusion
Aedifica presents a compelling funding case with sturdy fundamentals, together with 100% occupancy (tenant occupancy ~90%), long-term leases (~19-year WAULT), and an 8% EPRA yield. Pushed by Europe’s growing older inhabitants, demand for healthcare actual property is predicted to develop. Regardless of this, the inventory has been underneath strain as a consequence of rising rates of interest publish covid, impacting valuation. A easy scenario-based valuation implies enticing potential returns even when charges stay regular, with important upside if charges decline and restricted draw back in a barely greater price atmosphere. Dangers embody refinancing challenges, tenant focus, and potential demand shifts. General, Aedifica seems undervalued, providing a strong long-term alternative for buyers keen to make a directional wager on rates of interest with a top quality firm.
The writer of this evaluation does maintain shares in Aedifica on the time of writing, which can affect the attitude supplied.
This communication is for info and schooling functions solely and shouldn’t be taken as funding recommendation, a private advice, or a proposal of, or solicitation to purchase or promote, any monetary devices. This materials has been ready with out bearing in mind any explicit recipient’s funding targets or monetary scenario, and has not been ready in accordance with the authorized and regulatory necessities to advertise impartial analysis. Any references to previous or future efficiency of a monetary instrument, index or a packaged funding product should not, and shouldn’t be taken as, a dependable indicator of future outcomes. eToro makes no illustration and assumes no legal responsibility as to the accuracy or completeness of the content material of this publication.
Sources:https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Population_structure_and_ageingAedifica annual outcomes 2021, 2022, 2023 & 2024
Â







